Table 4 |
||||||
|
Descriptive, treatment and intermediate outcome measures by ethnic group |
||||||
|
Ethnic Group N (%) |
||||||
|
|
||||||
|
White |
South Asian |
Black African/Afro-Caribbean |
Other |
Not recorded |
p-value* |
|
|
|
||||||
|
Descriptive Measures |
||||||
|
|
||||||
|
Mean Age |
65.4 |
59.7 |
62.8 |
58.9 |
61.8 |
p < 0.001 |
|
Median (IQR) |
(54.2–74.4) |
(50.2–67.6) |
(52.3–69.4) |
(49.4–67.9) |
(49.2–71.7) |
|
|
|
||||||
|
Sex N (%) |
||||||
|
Male |
3463 (55.4) |
3140 (56.6) |
778 (45.9) |
750 (53.7) |
3507 (54.4) |
p < 0.001 |
|
Female |
2775 (44.4) |
2381 (42.9) |
913 (53.8) |
638 (45.7) |
2900 (45.0) |
|
|
Not recorded |
15 (0.2) |
30 (0.5) |
6 (0.4) |
9 (0.6) |
38 (0.6) |
|
|
|
||||||
|
Mean BMI |
28.7 |
27 |
28.5 |
27.3 |
27.3 |
p < 0.001 |
|
Median(IQR) |
(25.2–33.0) |
(24.3–30.4) |
(25.5–32.2) |
(24.6–31.1) |
(24.2–31.2) |
|
|
Not recorded N(%) |
870(13.9) |
495(8.9) |
233 (13.73) |
195 (14.0) |
2361(36.6) |
|
|
|
||||||
|
Smoker N(%) |
1152 (18.4) |
389 (7.0) |
190 (11.2) |
179 (12.8) |
822 (12.8) |
p < 0.001 |
|
Not recorded |
281 (4.5) |
430 (7.8) |
82 (4.8) |
94 (6.7) |
1508 (23.4) |
p < 0.001 |
|
|
||||||
|
Treatment Measures |
||||||
|
On insulin N (%) |
443 (7.1) |
263 (4.7) |
126 (7.4) |
80 (5.7) |
592 (9.2) |
p < 0.001 |
|
On statins N (%) |
1860 (29.8) |
1744 (31.4) |
425 (25.0) |
399 (28.6) |
1405 (21.8) |
p < 0.001 |
|
|
||||||
|
Intermediate Outcome Measures |
||||||
|
HbA1c < 7.4 N (%) |
2368 (37.9) |
1423 (25.6) |
540 (31.8) |
438 (31.4) |
1354 (21.0) |
p < 0.001 |
|
Not recorded |
1100 (17.6) |
1377 (24.8) |
313 (18.4) |
320 (22.9) |
3248 (50.4) |
|
|
BP < = 145 N (%) |
4094 (65.5) |
3711 (66.9) |
1095 (64.5) |
995 (71.2) |
3604 (55.9) |
p < 0.001 |
|
Not recorded |
119 (1.9) |
57 (1.0) |
21 (1.2) |
32 (2.3) |
1035 (16.1) |
|
|
Cholesterol < = 5 N(%) |
2537 (40.6) |
2275 (41.0) |
711 (41.9) |
580 (41.5) |
1609 (25.0) |
0.038 |
|
Not recorded |
1056 (16.9) |
1154 (20.8) |
265 (15.6) |
226 (16.2) |
2953 (45.8) |
p < 0.001 |
|
|
||||||
|
* note that the Chi-square tests for care process and intermediate outcome measures exclude the missing value category |
||||||
|
Soljak et al. International Journal for Equity in Health 2007 6:8 doi:10.1186/1475-9276-6-8 |
||||||